Home
About
Overview
Sharing Data
ORCID
Help
History (14)
"Clinical pharmacology studies in patients with renal impairment: past experience and regulatory perspectives".
RNA-seq: impact of RNA degradation on transcript quantification.
Integration of individualized and population-level molecular epidemiology data to model COVID-19 outcomes.
Intracellular transport: ER and mitochondria meet and greet along designated tracks.
Oral 5-FU alternatives for the treatment of head and neck cancer.
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Oral 5-FU alternatives for the treatment of head and neck cancer.
Oral 5-FU alternatives for the treatment of head and neck cancer. Oncology (Williston Park). 1998 Oct; 12(10 Suppl 7):35-8.
View in:
PubMed
subject areas
Administration, Oral
Antimetabolites, Antineoplastic
Antineoplastic Combined Chemotherapy Protocols
Chemotherapy, Adjuvant
Etoposide
Fluorouracil
Head and Neck Neoplasms
Humans
Hydroxyurea
Neoplasm Recurrence, Local
Tegafur
Uracil
authors with profiles
Daniel Haraf
Bruce E. Brockstein